BRAF V600E mutation correlates with aggressive clinico-pathological features but does not influence tumor recurrence in papillary thyroid carcinoma-10-year single-center results.

Tabriz, Navid; Grone, Johannes; Uslar, Verena; Tannapfel, Andrea; Weyhe, Dirk

Tabriz, Navid; Grone, Johannes; Uslar, Verena; Tannapfel, Andrea; Weyhe, Dirk.

Afiliação

Tabriz N; University Hospital for Visceral Surgery, Pius Hospital Oldenburg, Medical Campus University of Oldenburg, Oldenburg, Germany.
Grone J; University Hospital for Visceral Surgery, Pius Hospital Oldenburg, Medical Campus University of Oldenburg, Oldenburg, Germany.
Uslar V; University Hospital for Visceral Surgery, Pius Hospital Oldenburg, Medical Campus University of Oldenburg, Oldenburg, Germany.
Tannapfel A; Institute of Pathology, Ruhr-University Bochum, Bochum, Germany.
Weyhe D; University Hospital for Visceral Surgery, Pius Hospital Oldenburg, Medical Campus University of Oldenburg, Oldenburg, Germany.

Gland Surg ; 9(6): 1902-1913, 2020 Dec.

Article em En | MEDLINE | ID: mdl-33447541

Palavras-chave

BRAF V600E; Papillary thyroid carcinoma (PTC); extrathyroidal tumor growth; multifocal tumor growth; recurrence rate; tumor aggressiveness

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Risk_factors_studies Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google